2016 annual financial data
Capricor Therapeutics 2016 Operating margin
Direct answer
Operating margin was -532.16%.
Operating income was -16,976,518 USD and net income was -18,806,776 USD.
Operating cash flow was -15,801,620 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,190,106 USD
- Operating income
- -16,976,518 USD
- Net income
- -18,806,776 USD
- Operating cash flow
- -15,801,620 USD